Breaking News
Get 40% Off 0
🔎 See NVDA full ProTips for an instant risks or rewards Claim 40% OFF
Close

Novartis AG (NOVZn)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
80.16 0.00    0.00%
28/06 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  CH0012005267 
S/N:  904278
  • Volume: 0
  • Bid/Ask: 80.11 / 80.34
  • Day's Range: 79.94 - 80.34
Novartis 80.16 0.00 0.00%

NOVZn Income Statement

 
Featured here, the Income Statement (earnings report) for Novartis AG, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Revenue 11776 12092 13936 13208
Revenue 11423 11782 13622 12953
Other Revenue, Total 353 310 314 255
Cost of Revenue, Total 2987 3089 4006 3829
Gross Profit 8789 9003 9930 9379
Total Operating Expenses 8789 8642 10239 9876
Selling/General/Admin. Expenses, Total 3444 3093 3673 3401
Research & Development 2275 2356 2394 2425
Depreciation / Amortization 192 238 270 284
Interest Expense (Income) - Net Operating -217 -222 -224 -211
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 108 88 120 148
Operating Income 2987 3450 3697 3332
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets -33 96 -23 80
Other, Net 643 1802 951 512
Net Income Before Taxes 2377 1552 2769 2740
Provision for Income Taxes -261 39 452 446
Net Income After Taxes 2638 1513 2317 2294
Minority Interest 83 81 84 83
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 2638 1511 2316 2293
Total Extraordinary Items 5842 250 - -
Net Income 8480 1761 2316 2293
Total Adjustments to Net Income -5842 -250 - -
Income Available to Common Excluding Extraordinary Items 2638 1511 2316 2293
Dilution Adjustment 5840.14 246.25 -9.45 3.4
Diluted Net Income 2639.86 1514.75 2325.45 2289.6
Diluted Weighted Average Shares 2065 2075 2095 2120
Diluted EPS Excluding Extraordinary Items 1.28 0.73 1.11 1.08
DPS - Common Stock Primary Issue 3.92 - - -
Diluted Normalized EPS 0.878 0.984 1.07 0.954
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NOVN Comments

Write your thoughts about Novartis AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email